on Nasdaq Stockholm AB since December 12, 2017 and is included in the Nasdaq Nordic Large Cap segment. The total amount of shares in Arjo is 272,369,573, whereof 18,217,200 shares of series A and 254,152,373 shares of series B.

Sitting - Early Mobility | Arjo Sitting on edge of bed. Solutions to facilitate care and rehabilitation. Sitting facilitate good eye contact and personal interaction. For high-quality care. The Sara Combilizer enables patients to be placed into

We are a market-leading supplier of medical devices and medical solutions. Established in 1957. Find out more at Arjo. Arjo’s Guiding Principles promote a customer-oriented, winning and sustainable corporate culture in which we together create

Care | Arjo Arjo care. Proactive service approach to prevent issues before they occur and reduce the risk of costly equipment faults. For the safety of staff and patients. Ensuring your equipment performs as it should is as much our priority as

company’s operations shall be to, directly or indirectly through subsidiaries, engage in the manufacture and sale of medical technical equipment, and in any other activities compatible therewith.

Annual Report 2019 Arjo's Annual Report and Sustainability Report for 2019 was published on April 3. It is available for download under Reports & Presentations, and the digital version is available via the link below: https://arjo.inpublix.com/2019/en

be additional disclaimers and notices on the individual websites of companies within Arjo. The information published on this website is provided by Arjo AB and its affiliates (“Arjo”) for information purposes only and shall not be construed as ... recommendation, and this website should not be relied upon as the basis for any decision or action. The contents may not be comprehensive or updated. All information is provided in good faith but WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, and any

successful business. They provide more than just direction, but also reinforce your company’s brand for both visitors and employees alike.

Find out more how we streamlined the Arjo Value Chain. Est. in 1957. We are a market-leading supplier of medical devices and medical solutions.

Arjo Express - Streamlined Service Solutions Join Arjo Express for 24/7 access to maintenance requests, work reports, and compliance documentation. Sign up now for efficient service management

Born 1982. Deputy Board member since 2017. Represents Akademikerforeningen. Principal education and professional experience: M.Sc. in industrial design engineering, Chalmers University of Technology. Employed in Arjo’s subsidiary ArjoHuntleigh

surfaces | Arjo Meeting the infection control challenge when selecting a support surface. Ensuring the safety of patients and staff at all times. Find out more at Arjo.

Compliance | Arjo Find out more about Arjo’s Quality Policy & Regulatory Compliance. Market-leading supplier of medical devices and medical solutions. Find out more at Arjo.

| Arjo Working at Arjo can be the start of a career that really makes a difference. Apply today for our open positions and join us in the mission of empowering movement.

medical solutions | Arjo At Arjo, we are committed to improve the everyday lives of people affected by reduced mobility and age-related health challenges. Learn more at Arjo. Welcome!

investors and the media to the company’s virtual Capital Markets Day on November 2, 2020. During the Capital Markets Day, Arjo President & CEO, Joacim Lindoff, together with members of the Management Team, presented Arjo’s updated strategy and financial

All our websites should share the same visual identity and common user experience principles. Reference this section for how to build user-friendly websites that have the distinctive Arjo look.

hypotension or ready for more active rehabilitation. Find out more at Arjo. Progression to standing can be achieved gradually and securely.

Clinical evidence survey on Early Mobility in the ICU | Arjo Early mobilisation has been shown to be both safe and feasible for patients admitted to critical care. Download our clinical evidence summary.